|
|
.
See Category: Neoplasms
See Header: Benign neoplasm of kidney
ICD-10 (CM) Code and Descriptor
|
D30.02 |
Benign neoplasm of left kidney
|
D3002 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 53.46%
|
17.41%
|
8.37%
|
6.18%
|
4.98%
|
2.33%
|
1.99%
|
1.33%
|
1.03%
|
0.60%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D30.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
557
|
560
|
|
80048
|
METABOLIC PANEL TOTAL CA |
515
|
521
|
|
J3010
|
FENTANYL CITRATE INJECTION |
433
|
833
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
369
|
1,337
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
331
|
1,074
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
317
|
1,392
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
314
|
314
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
307
|
344
|
|
J2405
|
ONDANSETRON HCL INJECTION |
300
|
1,431
|
|
85027
|
COMPLETE CBC AUTOMATED |
290
|
296
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
289
|
328
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
278
|
700
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
253
|
7,367
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
247
|
247
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
236
|
22,985
|
|
50200
|
RENAL BIOPSY PERQ |
214
|
214
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
212
|
1,318
|
|
85610
|
PROTHROMBIN TIME |
205
|
205
|
|
76770
|
US EXAM ABDO BACK WALL COMP |
201
|
201
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
193
|
206
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D30.02 related to the following DRG Codes:
656-658
686-688
|
